Wells Fargo Initiates Coverage On Nuvalent with Overweight Rating, Announces Price Target of $116

3/30/2026
Impact: 80
Healthcare

Wells Fargo analyst Eva Fortea Verdejo has initiated coverage on Nuvalent (NASDAQ: NUVL) with an Overweight rating. The firm has set a price target of $116 for the stock.

AI summary, not financial advice

Share: